Skip to main content

Table 2 Predictors of eGFR changes

From: Effect of 48-week pegylated interferon α-2a or nucleos(t)ide analogue therapy on renal function in Chinese patients with chronic hepatitis B

 

eGFR (CKD-EPI)

eGFR (MDRD)

Estimate

Standard error

P valuea

Estimate

Standard error

P valuea

Age

−0.907

0.055

<0.0001

−0.933

0.122

<0.0001

Sex

1.410

1.105

0.203

4.916

2.473

0.048

HBV DNA

0.211

0.214

0.325

0.502

0.573

0.382

ALT

−0.006

0.004

0.102

−0.014

0.009

0.146

AST

0.006

0.005

0.254

0.014

0.013

0.296

BUN

−0.492

0.107

<0.0001

−1.028

0.266

0.0001

ADV

−14.522

1.397

<0.0001

−27.352

2.759

<0.0001

ETV

1.595

1.430

0.266

1.963

3.640

0.590

PEG-IFN-α-2a

2.766

1.306

0.035

7.365

3.496

0.036

  1. aResults from the linear mixed effects model for repeated measures. LdT therapy was set as reference